Study Stopped
Enrollment goal not met in allotted recruitment period
Concurrent Training in Type 2 Diabetes
CONTRADIA
Effects of Concurrent Resistance Exercise and High-intensity Interval Exercise Training on Skeletal Muscle Adaptations in Individuals With Type 2 Diabetes Mellitus
3 other identifiers
interventional
4
1 country
1
Brief Summary
It is recommended that individuals perform a combination of resistance exercise (RE) and endurance exercise. Lack of time is often cited as a reason for being unable to meet current exercise guidelines. Therefore, combining both forms in one session may be beneficial. However, research continues to elucidate whether interference of adaptive outcomes occurs when RE and endurance exercise are performed concurrently. A proposed interference effect suggests that concurrent training may dampen RE-induced adaptations (e.g., muscle strength and growth) compared to RE only. The propose of this investigation is to determine the effects of concurrent RE and high-intensity interval training (HIIT), compared to RE only, on muscle health and cardiovascular risk in sedentary, middle-aged (40-65 years) who are overweight/obese with type 2 diabetes mellitus (T2DM). The investigators will measure the effects on muscle strength, muscle growth, cardiovascular fitness, glycaemic control and markers of cardiovascular risk before and after an 8-week training program. Data will be obtained through the analysis of skeletal muscle samples, blood samples, magnetic resonance imaging, questionnaires and exercise performance tests.It is hypothesized that concurrent RE + HIIT will amplify the exercise-induced muscle growth response, which will result in greater satellite cell content, compared to RE alone. As a result, this will lead to greater skeletal muscle mass and strength after RE + HIIT compared to RE in isolation. A finding that concurrent resistance training and HIIT does not impede muscle adaptations could offer future strategies to minimize exercise time commitment whilst still maximizing the physiological benefits of both resistance and endurance exercise through a single training session. This may therefore provide an effective exercise strategy in the prevention and/or treatment of T2DM.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable type-2-diabetes-mellitus
Started Dec 2017
Shorter than P25 for not_applicable type-2-diabetes-mellitus
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 4, 2017
CompletedFirst Posted
Study publicly available on registry
September 12, 2017
CompletedStudy Start
First participant enrolled
December 6, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 12, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
July 12, 2018
CompletedJuly 17, 2018
July 1, 2018
7 months
September 4, 2017
July 13, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in fibre-type specific satellite cell content
Assessed using immunofluorescence microscopy (Pax7-positive cells)
Prior to the 8-week training intervention and 72 hours after the last training session
Secondary Outcomes (9)
Change in muscle-specific gene expression related to growth adaptations
Prior to the 8-week training intervention and 72 hours after the last training session
Change in muscle fibre size
Prior to the 8-week training intervention and 72 hours after the last training session
Change in muscle size
Prior to the 8-week training intervention and 48 hours after the last training session
Change in isometric muscle strength
Prior to the 8-week training intervention and 6 days after the last training session
Change in isokinetic muscle strength
Prior to the 8-week training intervention and 6 days after the last training session
- +4 more secondary outcomes
Study Arms (2)
RE training only
OTHERRE only - Progressive resistance exercise training only (leg extension, leg step up, chest press and pull down).
Concurrent RE + HIIT
EXPERIMENTALRE + HIIT - Progressive resistance exercise training (leg extension, leg step up, chest press and pull down) followed by HIIT (10 x 1 min at 90% heart rate maximum).
Interventions
8 weeks of supervised training. Three times weekly with no more than two non-consecutive days without exercise.
8 weeks of supervised training. Three times weekly with no more than two non-consecutive days without exercise. Concurrent training: RE followed by HIIT within the same session.
Eligibility Criteria
You may qualify if:
- Male sex
- White British/European
- Aged between 40 and 65 years at the time of screening
- Have a body mass index (BMI; body weight/height in m2) between 27 and 40 kg/m2
- Sedentary/untrained for at least 1 year (based on physical activity self-reports of fewer than two sessions of structured exercise per week last \<30 min)
- T2DM (American Diabetes Association 2014) for more than 1 year
- Central obesity (defined as waist circumference ≥94 cm for males)
You may not qualify if:
- Currently involved in research or have recently (\<6 months) been involved in any research prior to recruitment
- Any condition limiting or contraindicating physical activity; including diabetic peripheral neuropathy, and coronary or peripheral artery disease
- Previous myocardial infarction, previous or current angina, shortness of breath, or other symptoms suggestive of heart failure
- Insulin medication
- HbA1c more than 75 mmol/mol (9%)
- Uncontrollable hypertension: systolic blood pressure ≥160 mmHg and diastolic blood pressure ≥100 mmHg
- Not weight stable for the last three months
- Smokers (within the last 12 months)
- Anticoagulant medication, such as warfarin or newer anticoagulant drugs. If participants are on aspirin medication, this would need to be stopped for 3 days prior to and during the day of any biopsy visit unless contraindicated (in which case participants would be excluded).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Birminghamlead
- Loughborough Universitycollaborator
- Metabolic Fitness Association, Italycollaborator
- Università degli studi di Roma Foro Italicocollaborator
Study Sites (1)
School of Sport, Exercise and Rehabilitation Sciences, University of Birmingham
Birmingham, B15 2TT, United Kingdom
Related Publications (2)
American Diabetes Association. Standards of medical care in diabetes--2014. Diabetes Care. 2014 Jan;37 Suppl 1:S14-80. doi: 10.2337/dc14-S014. No abstract available.
PMID: 24357209BACKGROUNDBabcock L, Escano M, D'Lugos A, Todd K, Murach K, Luden N. Concurrent aerobic exercise interferes with the satellite cell response to acute resistance exercise. Am J Physiol Regul Integr Comp Physiol. 2012 Jun 15;302(12):R1458-65. doi: 10.1152/ajpregu.00035.2012. Epub 2012 Apr 4.
PMID: 22492813BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Professor M Nimmo, PhD
University of Birmingham
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 4, 2017
First Posted
September 12, 2017
Study Start
December 6, 2017
Primary Completion
July 12, 2018
Study Completion
July 12, 2018
Last Updated
July 17, 2018
Record last verified: 2018-07